Stay updated on Tisotumab Vedotin Continued Treatment in Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the Tisotumab Vedotin Continued Treatment in Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Tisotumab Vedotin Continued Treatment in Solid Tumors Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The revision label in the page footer updated from v3.4.0 to v3.4.1; no changes to study details or eligibility information are visible.
    Difference
    0.1%
    Check dated 2026-02-04T17:53:36.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    UI and labeling updates include showing the glossary toggle ('Show glossary'), capitalization/wording tweaks (e.g., 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data'), and a new revision tag 'Revision: v3.4.0'. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-28T09:57:09.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    A new Revision: v3.3.4 notice was added and the Revision: v3.3.3 notice was removed from the page.
    Difference
    0.1%
    Check dated 2026-01-14T03:20:41.000Z thumbnail image
  5. Check
    44 days ago
    Change Detected
    Summary
    Added a Locations section with Florida as a site. Removed the old Florida Locations heading and the HHS Vulnerability Disclosure footer; page revision updated to v3.3.3.
    Difference
    0.2%
    Check dated 2025-12-23T20:20:58.000Z thumbnail image
  6. Check
    72 days ago
    Change Detected
    Summary
    Revision: v3.3.2 added; Revision: v3.2.0 removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-25T10:44:11.000Z thumbnail image
  7. Check
    80 days ago
    Change Detected
    Summary
    The government funding lapse notice was removed from the page. Trial details, eligibility criteria, and study results remain unchanged.
    Difference
    0.4%
    Check dated 2025-11-18T06:57:58.000Z thumbnail image

Stay in the know with updates to Tisotumab Vedotin Continued Treatment in Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Tisotumab Vedotin Continued Treatment in Solid Tumors Clinical Trial page.